{Reference Type}: Journal Article
{Title}: Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15 years.
{Author}: Martin M;Trouvin JH;
{Journal}: Transfus Clin Biol
{Volume}: 20
{Issue}: 4
{Year}: Sep 2013
{Factor}: 2.126
{DOI}: 10.1016/j.tracli.2013.06.001
{Abstract}: Risk of transmission of Creutzfeldt-Jakob disease (infectious agent, responsible of spongiform encephalopathy) via blood and blood components (including the plasma-derived medicinal products such as coagulation factors and immunoglobulins) have been a subject of concern for Health authorities since the early 1980s, with a regain of interest in the 1990s, with the bovine spongiform encephalopathy outbreak followed few years after with the notification of the first cases of variant Creutzfeldt-Jakob disease in humans. The risk-analysis and measures taken by the French authorities in the period 1990-2010 will be described with the various assumptions and working hypothesis used and revisited as new findings become available.